Pediatric pharmacology : the path clears for a noble mission.
Unlabeled use of drugs in children occurs frequently and contributes to the therapeutic orphan dilemma.
This situation can no longer be condoned; few acceptable reasons still exist for not evaluating potentially effective drug therapy in children.
An apparent lack of research funds is not one of these reasons; only allocation of these funds to pediatric pharmacology is found wanting.
Availability of clinical pharmacology programs, pediatric pharmacology manpower, sensitive analytical techniques, and acceptable ethical approaches to pediatric research reveal that drug evaluation is feasible in children.
Mots-clés Pascal : Recherche développement, Recherche scientifique, Industrie pharmaceutique, Pédiatrie, Médicament, Financement, Economie santé, Médicament orphelin
Mots-clés Pascal anglais : Research and development, Scientific research, Pharmaceutical industry, Pediatrics, Drug, Financing, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0368094
Code Inist : 002B30A08. Création : 199406.